Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy

Bioconjugate Chemistry

Volumn 24, Issue 9, 2013, Pages 1429-1434

  Mieszawska, Aneta J ^a   Kim, Yongtae ^b   Gianella, Anita ^a   Van Rooy, Inge ^a   Priem, Bram ^a   Labarre, Matthew P ^c   Ozcan, Canturk ^a   Cormode, David P ^d   Petrov, Artiom ^a   Langer, Robert ^b   Farokhzad, Omid C ^e   Fayad, Zahi A ^a   Mulder, Willem J M ^a,f  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; CONTROLLED DRUG DELIVERY; DIAGNOSIS; DISEASE CONTROL; DISEASES; FLUORESCENCE IMAGING; INFRARED DEVICES; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; TUMORS;

'CURRENT; ADVANCED TREATMENT; COMPLEX NANOPARTICLES; DOXORUBICIN; DUAL-MODALITY; IMAGE-GUIDED; LIPID NANOPARTICLES; MULTI-FUNCTIONAL NANOPARTICLES; MULTICOMPONENTS; SORAFENIB;

NANOPARTICLES;

CYCLODEXTRIN; DOXORUBICIN; DYE; GOLD NANOPARTICLE; LIPID NANOPARTICLE; NANOCRYSTAL; NANOPARTICLE; POLYGLACTIN; SORAFENIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL VIABILITY; CHEMICAL MODIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DRUG RELEASE; ESTERIFICATION; FEMALE; FLUORESCENCE IMAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIGHT SCATTERING; MICROFLUIDICS; MOUSE; MULTIMODALITY CANCER THERAPY; NANOENCAPSULATION; NANOFABRICATION; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SUSTAINED DRUG RELEASE; SYNTHESIS; TUMOR LOCALIZATION;

MUS;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LACTIC ACID; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASMS; NIACINAMIDE; OPTICAL IMAGING; PHENYLUREA COMPOUNDS; POLYGLYCOLIC ACID;

EID: 84884409747     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc400166j     Document Type: Article

References (38)

1. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., and Langer, R. (2007) Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2, 751-60 (Pubitemid 350223348)
2. Torchilin, V. P. (2005) Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discovery 4, 145-60 (Pubitemid 40282557)
3. Wagner, V., Dullaart, A., Bock, A. K., and Zweck, A. (2006) The emerging nanomedicine landscape Nat. Biotechnol. 24, 1211-7 (Pubitemid 44564760)
4. Dalwadi, G. and Sunderland, B. (2009) An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles Eur. J. Pharm. Biopharm. 71, 231-42
5. Wischke, C. and Schwendeman, S. P. (2008) Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles Int. J. Pharm. 364, 298-327
6. Zhang, L., Chan, J. M., Gu, F. X., Rhee, J. W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., and Farokhzad, O. C. (2008) Self-assembled lipid - polymer hybrid nanoparticles: a robust drug delivery platform ACS Nano 2, 1696-702
7. Avgoustakis, K., Beletsi, A., Panagi, Z., Klepetsanis, P., Karydas, A. G., and Ithakissios, D. S. (2002) PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties J. Controlled Release 79, 123-35 (Pubitemid 34164166)
8. Cormode, D. P., Roessl, E., Thran, A., Skajaa, T., Gordon, R. E., Schlomka, J. P., Fuster, V., Fisher, E. A., Mulder, W. J., Proksa, R., and Fayad, Z. A. (2010) Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles Radiology 256, 774-82
9. Gianella, A., Jarzyna, P. A., Mani, V., Ramachandran, S., Calcagno, C., Tang, J., Kann, B., Dijk, W. J., Thijssen, V. L., Griffioen, A. W., Storm, G., Fayad, Z. A., and Mulder, W. J. (2011) Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer ACS Nano 5, 4422-33
10. Hrkach, J., Von Hoff, D., Mukkaram Ali, M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., Low, S., McDonnell, K., Peeke, E., Retnarajan, B., Sabnis, A., Schnipper, E., Song, J. J., Song, Y. H., Summa, J., Tompsett, D., Troiano, G., Van Geen Hoven, T., Wright, J., LoRusso, P., Kantoff, P. W., Bander, N. H., Sweeney, C., Farokhzad, O. C., Langer, R., and Zale, S. (2012) Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile Sci. Transl. Med. 4, 128ra39
11. Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., and Sasisekharan, R. (2005) Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature 436, 568-72 (Pubitemid 41112931)
12. Xiong, S., Zhao, X., Heng, B. C., Ng, K. W., and Loo, J. S. (2011) Cellular uptake of Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method Biotechnol. J. 6, 501-8
13. Kim, Y., Lee Chung, B., Ma, M., Mulder, W. J., Fayad, Z. A., Farokhzad, O. C., and Langer, R. (2012) Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices Nano Lett. 12, 3587-91
14. Marre, S. and Jensen, K. F. (2010) Synthesis of micro and nanostructures in microfluidic systems Chem. Soc. Rev. 39, 1183-202
15. Duyndam, M. C., van Berkel, M. P., Dorsman, J. C., Rockx, D. A., Pinedo, H. M., and Boven, E. (2007) Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells Biochem. Pharmacol. 74, 191-201 (Pubitemid 46890812)
16. Fornari, F. A., Randolph, J. K., Yalowich, J. C., Ritke, M. K., and Gewirtz, D. A. (1994) Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells Mol. Pharmacol. 45, 649-56 (Pubitemid 24139191)
17. Hainfeld, J. F., Slatkin, D. N., Focella, T. M., and Smilowitz, H. M. (2006) Gold nanoparticles: a new X-ray contrast agent Br. J. Radiol. 79, 248-53
18. Xu, C., Tung, G. A., and Sun, S. (2008) Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography Chem. Mater. 20, 4167-4169
19. Johnsson, M. and Edwards, K. (2003) Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids Biophys. J. 85, 3839-47 (Pubitemid 37490293)
20. Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., and Langer, R. (1994) Biodegradable long-circulating polymeric nanospheres Science 263, 1600-3 (Pubitemid 24128361)
21. Wilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., and Lynch, M. (2008) Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling Mol. Cancer Ther. 7, 3129-40
22. Kerbel, R. S. and Kamen, B. A. (2004) The anti-angiogenic basis of metronomic chemotherapy Nat. Rev. Cancer 4, 423-36 (Pubitemid 38745528)
23. Ma, J. and Waxman, D. J. (2008) Combination of antiangiogenesis with chemotherapy for more effective cancer treatment Mol. Cancer Ther. 7, 3670-84
24. Teoh, D. and Secord, A. A. (2012) Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer Int. J. Gynecol. Cancer 22, 348-59
25. Iyer, A. K., Khaled, G., Fang, J., and Maeda, H. (2006) Exploiting the enhanced permeability and retention effect for tumor targeting Drug Discovery Today 11, 812-8 (Pubitemid 44280021)
26. Mattheolabakis, G., Rigas, B., and Constantinides, P. P. (2012) Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives Nanomedicine 7, 1577-90
27. Jia, Y., Yuan, M., Yuan, H., Huang, X., Sui, X., Cui, X., Tang, F., Peng, J., Chen, J., Lu, S., Xu, W., Zhang, L., and Guo, Q. (2012) Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery Int. J. Nanomed. 7, 1697-708
28. Yoo, H. S., Oh, J. E., Lee, K. H., and Park, T. G. (1999) Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release Pharm. Res. 16, 1114-8 (Pubitemid 29368162)
29. Stella, V. J. and Rajewski, R. A. (1997) Cyclodextrins: their future in drug formulation and delivery Pharm. Res. 14, 556-67 (Pubitemid 27220271)
30. Uekama, K., Hirayama, F., and Irie, T. (1998) Cyclodextrin drug carrier systems Chem. Rev. 98, 2045-2076 (Pubitemid 128633447)
31. Tao, H. Q., Meng, Q., Li, M. H., Yu, H., Liu, M. F., Du, D., Sun, S. L., Yang, H. C., Wang, Y. M., Ye, W., Yang, L. Z., Zhu, D. L., Jiang, C. L., and Peng, H. S. (2013) HP-beta-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats Naunyn Schmiedebergs Arch. Pharmacol. 386, 61-70
32. Nguyen, N. T. and Wu, Z. (2005) Micromixers-a review J. Micromech. Microeng. 15, R1
33. Galper, M. W., Saung, M. T., Fuster, V., Roessl, E., Thran, A., Proksa, R., Fayad, Z. A., and Cormode, D. P. (2012) Effect of computed tomography scanning parameters on gold nanoparticle and iodine contrast Invest. Radiol. 47, 475-81
34. Mieszawska, A. J., Gianella, A., Cormode, D. P., Zhao, Y., Meijerink, A., Langer, R., Farokhzad, O. C., Fayad, Z. A., and Mulder, W. J. (2012) Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging Chem. Commun. 48, 5835-7
35. McMahon, K. M., Mutharasan, R. K., Tripathy, S., Veliceasa, D., Bobeica, M., Shumaker, D. K., Luthi, A. J., Helfand, B. T., Ardehali, H., Mirkin, C. A., Volpert, O., and Thaxton, C. S. (2011) Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery Nano Lett. 11, 1208-14
36. Zheng, D., Giljohann, D. A., Chen, D. L., Massich, M. D., Wang, X. Q., Iordanov, H., Mirkin, C. A., and Paller, A. S. (2012) Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation Proc. Natl. Acad. Sci. U. S. A. 109, 11975-80
37. Brust, M., Walker, M., Bethell, D., Schiffrin, D. J., and Whyman, R. (1994) Synthesis of thiol-derivatised gold nanoparticles in a two-phase Liquid-Liquid system J. Chem. Soc., Chem. Commun. 7, 801-802
38. Guo, R., Song, Y., Wang, G., and Murray, R. W. (2005) Does core size matter in the kinetics of ligand exchanges of monolayer-protected Au clusters? J. Am. Chem. Soc. 127, 2752-7 (Pubitemid 40327838)